Kircik LH - Search Results

1

Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents.

Eichenfield LF, Hebert AA, Harper JC, Baldwin H, Bhatia N, Gold LS, Kircik LH, Graber E, Tanghetti EA, Alexis AF, Del Rosso JQ. Eichenfield LF, et al. Among authors: kircik lh. J Drugs Dermatol. 2024 Dec 1;23(12):1049-1057. doi: 10.36849/jdd.8643. J Drugs Dermatol. 2024. PMID: 39630680 Clinical Trial.

2

Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.

Tanghetti E, Kircik L, Wilson D, Dhawan S. Tanghetti E, et al. J Drugs Dermatol. 2008 Jun;7(6):534-8. J Drugs Dermatol. 2008. PMID: 18561583 Clinical Trial.

3

Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.

Kircik L, Green L, Thiboutot D, Tanghetti E, Wilson D, Dhawan S, Parr L. Kircik L, et al. J Drugs Dermatol. 2009 Sep;8(9):812-8. J Drugs Dermatol. 2009. PMID: 19746673 Clinical Trial.

4

The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris.

Hoffman LK, Del Rosso JQ, Kircik LH. Hoffman LK, et al. Among authors: kircik lh. J Drugs Dermatol. 2017 Jun 1;16(6):534-538. J Drugs Dermatol. 2017. PMID: 28686770 Clinical Trial.

5

Clobetasol Emulsion Foam and Calcipotriene 0.005% Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis.

Bhatia N, Kircik L. Bhatia N, et al. J Drugs Dermatol. 2018 Mar 1;17(3):342-346. J Drugs Dermatol. 2018. PMID: 29537452

6

Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.

Tanghetti E, Harper J, Baldwin H, Kircik L, Bai Z, Alvandi N. Tanghetti E, et al. J Drugs Dermatol. 2018 Nov 1;17(11):1192-1198. J Drugs Dermatol. 2018. PMID: 30500139 Clinical Trial.

7

Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.

Tanghetti E, Harper J, Baldwin H, Kircik L, Bai Z, Alvandi N. Tanghetti E, et al. J Drugs Dermatol. 2018 Nov 1;17(11):1192-1198. J Drugs Dermatol. 2018. PMID: 30500140 Clinical Trial.

8

Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.

Tanghetti E, Harper J, Baldwin H, Kircik L, Bai Z, Alvandi N. Tanghetti E, et al. J Drugs Dermatol. 2018 Nov 1;17(11):1192-1198. J Drugs Dermatol. 2018. PMID: 30500141 Clinical Trial.

9

The Effect of Calcipotriene-Betamethasone Dipropionate Aerosol Foam versus Vehicle on Target Lesions in Moderate Severity Plaque Psoriasis: Focus on Elbows and Knees.

Del Rosso JQ, Kircik LH. Del Rosso JQ, et al. Among authors: kircik lh. J Drugs Dermatol. 2019 Apr 1;18(4):358-361. J Drugs Dermatol. 2019. PMID: 31012564 Clinical Trial.

10

Once-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex.

Kircik LH, Gold LS, Beer K, Tan J, Baldwin H, Guenin E, Kang R, Varughese J. Kircik LH, et al. J Drugs Dermatol. 2020 Aug 1;19(8):777-783. doi: 10.36849/JDD.2020.5249. J Drugs Dermatol. 2020. PMID: 32845584 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results